Plunkett Research Online: Johnson & Johnson

JOHNSON & JOHNSON (JNJ:NYS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focu.....
Johnson & Johnson
Ticker: JNJ
Exchange: NYS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 732 524-0400
Fax: 732 214-0332
Address: One Johnson & Johnson Plaza
New Brunswick, NJ 08933 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Personal Health Care & Hygiene Products
Sterilization Products
Surgical Products
Pharmaceuticals
Contact Lenses
Medical Equipment
1. Johnson & Johnson94,193,000,000
2. Roche Holding AG78,403,040,000
3. Eli Lilly and Company65,179,000,000
4. Merck & Co Inc65,011,000,000
5. Pfizer Inc62,579,000,000
6. AbbVie Inc61,160,000,000
7. AstraZeneca plc58,739,000,000
8. Novartis AG56,674,000,000
9. Sanofi SA53,345,000,000
10. Bayer AG52,042,090,000
Contacts
Description
Joaquin DuatoCEO/Chairman of the Board/Director
Joseph WolkCFO/Executive VP
Jennifer TaubertChairman, Divisional/Executive VP
Timothy SchmidChairman, Divisional/Executive VP
Robert DeckerChief Accounting Officer/Controller
James SwansonChief Information Officer/Executive VP
Elizabeth ForminardChief Legal Officer/Executive VP
Kathryn WengelChief Risk Officer/Executive VP/Other Executive Officer
Eugene WoodsDirector
Nadja WestDirector
Mark WeinbergerDirector
Jennifer DoudnaDirector
John MorikisDirector
Marillyn HewsonDirector
Paula JohnsonDirector
Hubert JolyDirector
Daniel PintoDirector
Mary BeckerleDirector
Mark McClellanDirector
John ReedExecutive VP, Divisional
Vanessa BroadhurstExecutive VP, Divisional
Kristen MulhollandExecutive VP/Other Executive Officer
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focu.....
See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
Financial Details Compare to Industry Averages Build Custom Table Compare Companies
$USD, In whole numbers,
except marked * or %		202520242023202220212020
Financials
    Revenue94,193,000,00088,821,000,00085,159,000,00094,943,000,00093,775,000,00082,584,000,000
    Cost of Revenue30,256,000,00027,471,000,00026,553,000,00031,089,000,00029,855,000,00028,427,000,000
    Gross Margin %67.8869.0768.8267.2668.1665.58
    R&D Expense14,665,000,00017,232,000,00015,085,000,00014,603,000,00014,714,000,00012,159,000,000
    Operating Income25,596,000,00021,249,000,00022,009,000,00024,486,000,00024,547,000,00019,914,000,000
    Operating Margin %27.1723.9225.8425.7926.1824.11
    SGA Expense23,676,000,00022,869,000,00021,512,000,00024,765,000,00024,659,000,00022,084,000,000
    Net Income26,804,000,00014,066,000,00035,153,000,00017,941,000,00020,878,000,00014,714,000,000
    Earnings Per Share11.135.8413.886.837.935.59
    Dividends5.144.914.704.454.193.98
    Book Value Per Share32.9229.1529.5928.5326.6924.49
    Operating Cash Flow24,530,000,00024,266,000,00022,791,000,00021,194,000,00023,410,000,00023,536,000,000
    Capital Expenditure5,217,000,0006,207,000,0005,013,000,0004,009,000,0003,652,000,0003,347,000,000
    Free Cash Flow19,313,000,00018,059,000,00017,778,000,00017,185,000,00019,758,000,00020,189,000,000
Profitability
    EBITDA41,055,000,00024,781,000,00023,320,000,00028,971,000,00030,349,000,00023,929,000,000
    Return on Assets %14.138.0919.819.7111.708.85
    Return on Equity %35.0320.0648.2923.7930.4123.97
    Net Margin %28.4615.8441.2818.9022.2617.82
    Assets Turnover0.500.510.480.510.530.50
    Financial Leverage2.442.522.442.442.462.76
Brands, Divisions and Affiliates Top Salaries
Johnson & Johnson Innovative Medicine
Johnson & Johnson MedTech
NameTitleSalary (US$)Bonus (US$)
Joaquin DuatoCEO/Chairman of the Board/Director1,600,0000
Joseph WolkCFO/Executive VP1,240,6460
Jennifer TaubertChairman, Divisional/Executive VP1,220,3080
John ReedExecutive VP, Divisional1,220,3080
Timothy SchmidChairman, Divisional/Executive VP942,3080
Other Thoughts Corporate Culture

Apparent Female Officers or Directors:

Affordable Subscriptions to the Plunkett Research Business & Industry Database

 

Search the List of Industries We Cover with Analysis, Statistics, Companies, & Market Research

Reports<span>Corporate Benchmarks</span>

ReportsCorporate Benchmarks

Company-specific financial benchmark and operating metrics (KPI) reports. Each company is benchmarked to its industry and to its peers. Each report is about 65 pages of vital data. Available on each of 4,000 major companies. Updated frequently.
More details
Industry Almanacs

Industry Almanacs

Our award-winning, industry-specific almanacs offer vital insights, trends analysis, industry statistics and profiles of leading firms. Available on each of about 40 broad business sectors. Updated annually. Ideal for libraries, academics and researchers.
More details
Reports<span>Industry Analytics</span>

ReportsIndustry Analytics

Industry-specific reports containing market sizing, revenues history and forecasts, analysis of financial averages, and profiles of top companies. Each report is about 70 pages. Available on each of 500+ industries. Updated frequently.
More details
Custom research

Custom research

Our experienced team conducts competitive intelligence studies, surveys (both B2B and B2C) and special market research assignments for top corporations and institutions, anywhere in the world.
More details